content/01.abstract.md:3:metabolome
content/01.abstract.md:3:metabolome
content/01.abstract.md:3:metabolomics
content/01.abstract.md:3:metabolomics
content/01.abstract.md:3:multiomic
content/01.abstract.md:3:multiomic
content/01.abstract.md:3:multiomics
content/01.abstract.md:3:multiomics
content/01.abstract.md:3:multiomics
content/01.abstract.md:3:multiomics
content/01.abstract.md:3:omes
content/01.abstract.md:3:omic
content/01.abstract.md:3:omics
content/01.abstract.md:3:proteome
content/01.abstract.md:3:proteome
content/01.abstract.md:3:proteomics
content/01.abstract.md:3:proteomics
content/01.abstract.md:3:spectrometry
content/01.abstract.md:3:spectrometry
content/01.abstract.md:3:spectrometry
content/01.abstract.md:3:transcriptome
content/02.introduction.md:3:biomolecule
content/02.introduction.md:3:phenotypes
content/02.introduction.md:5:phenotypic
content/02.introduction.md:8:noncoding
content/02.introduction.md:8:ribozymes
content/02.introduction.md:8:RNAs
content/02.introduction.md:9:commoditized
content/02.introduction.md:9:measurment
content/02.introduction.md:9:mRNA
content/02.introduction.md:9:transcriptomics
content/02.introduction.md:10:quantitations
content/02.introduction.md:12:proteomics
content/02.introduction.md:13:Proteomics
content/02.introduction.md:14:mechansims
content/02.introduction.md:14:Proteomics
content/02.introduction.md:18:acylation
content/02.introduction.md:18:allosteric
content/02.introduction.md:18:proteolysis
content/02.introduction.md:18:translational
content/02.introduction.md:21:lipidomics
content/02.introduction.md:21:metabolomics
content/02.introduction.md:21:metabolomics
content/02.introduction.md:22:chromatograhpy
content/02.introduction.md:22:GC
content/02.introduction.md:22:metabolomics
content/02.introduction.md:22:spectrometry
content/02.introduction.md:23:metabolomics
content/02.introduction.md:23:NMR
content/02.introduction.md:25:multiomics
content/02.introduction.md:25:omic
content/02.introduction.md:26:metabolomic
content/02.introduction.md:26:proteomic
content/02.introduction.md:27:metabolomes
content/02.introduction.md:27:proteomes
content/02.introduction.md:28:metabolomes
content/02.introduction.md:28:multiomic
content/02.introduction.md:28:multiomics
content/02.introduction.md:28:omes
content/02.introduction.md:28:proteomes
content/02.introduction.md:30:dataset
content/02.introduction.md:30:multiomics
content/02.introduction.md:31:Multiomic
content/02.introduction.md:32:multiomic
content/02.introduction.md:35:multiomic
content/02.introduction.md:35:phenotypes
content/02.introduction.md:35:qualitity
content/02.introduction.md:35:respirometry
content/02.introduction.md:36:multiomic
content/02.introduction.md:36:multiomic
content/02.introduction.md:36:omic
content/02.introduction.md:37:Misra
content/02.introduction.md:37:multiomic
content/02.introduction.md:37:multiomics
content/02.introduction.md:38:metabolomics
content/02.introduction.md:38:multiomic
content/02.introduction.md:40:metabolomics
content/02.introduction.md:40:multiomics
content/02.introduction.md:40:proteomics
content/02.introduction.md:42:prepartion
content/02.introduction.md:51:omic
content/02.introduction.md:51:omic
content/02.introduction.md:53:ATAC
content/02.introduction.md:54:microarrays
content/02.introduction.md:54:nanopore
content/02.introduction.md:54:pacbio
content/02.introduction.md:54:transcriptomics
content/02.introduction.md:55:CETSA
content/02.introduction.md:55:interactomics
content/02.introduction.md:55:proteome
content/02.introduction.md:55:proteomics
content/02.introduction.md:55:proteomics
content/02.introduction.md:55:PTMomics
content/02.introduction.md:56:lipidomics
content/02.introduction.md:56:metabolomics
content/02.introduction.md:56:metabolomics
content/02.introduction.md:58:omics
content/02.introduction.md:59:intergration
content/02.introduction.md:61:multiomics
content/02.introduction.md:62:multiomics
content/03.sample-preparation.md:1:Omic
content/03.sample-preparation.md:3:biomolecules
content/03.sample-preparation.md:3:biomolecules
content/03.sample-preparation.md:3:metabolomics
content/03.sample-preparation.md:3:omic
content/03.sample-preparation.md:3:physicochemical
content/03.sample-preparation.md:3:proteomics
content/03.sample-preparation.md:3:spectrometry
content/03.sample-preparation.md:6:proteomics
content/03.sample-preparation.md:8:alkylation
content/03.sample-preparation.md:8:cysteines
content/03.sample-preparation.md:8:electrophoresis
content/03.sample-preparation.md:8:ESI
content/03.sample-preparation.md:8:fractionate
content/03.sample-preparation.md:8:orbitrap
content/03.sample-preparation.md:8:spectrometry
content/03.sample-preparation.md:13:metabolomics
content/03.sample-preparation.md:15:metabolomics
content/03.sample-preparation.md:19:metabolomics
content/03.sample-preparation.md:21:lipidomics
content/03.sample-preparation.md:25:omics
content/03.sample-preparation.md:25:prepatation
content/03.sample-preparation.md:27:omics
content/03.sample-preparation.md:28:multiomic
content/03.sample-preparation.md:36:Multiomic
content/03.sample-preparation.md:38:Metabolomics
content/03.sample-preparation.md:38:Proteomics
content/03.sample-preparation.md:40:Lipidomic
content/03.sample-preparation.md:40:Metabolomic
content/03.sample-preparation.md:40:MPLEx
content/03.sample-preparation.md:40:Proteomic
content/03.sample-preparation.md:42:metabolomics
content/03.sample-preparation.md:42:omic
content/03.sample-preparation.md:42:proteomics
content/03.sample-preparation.md:42:spectrometry
content/03.sample-preparation.md:44:Omics
content/04. methodology.md:1:omics
content/04. methodology.md:1:spectrometry
content/04. methodology.md:3:proteomics
content/04. methodology.md:5:proteomics
content/04. methodology.md:11:proteome
content/04. methodology.md:13:chromatographic
content/04. methodology.md:13:proteomic
content/04. methodology.md:14:biomarker
content/04. methodology.md:14:multiomics
content/04. methodology.md:14:repeatiability
content/04. methodology.md:17:fungas
content/04. methodology.md:17:MALDI
content/04. methodology.md:17:MALDI
content/04. methodology.md:17:proteome
content/04. methodology.md:21:metabolomics
content/04. methodology.md:23:lipidomics
content/04. methodology.md:23:metabolomics
content/04. methodology.md:23:spectrometry
content/04. methodology.md:24:MALDI
content/04. methodology.md:24:MALDI
content/04. methodology.md:24:tof
content/04. methodology.md:27:MALDI
content/04. methodology.md:28:FTICR
content/04. methodology.md:28:MALDI
content/04. methodology.md:28:MALDI
content/04. methodology.md:28:TOF
content/04. methodology.md:31:spectrometry
content/04. methodology.md:34:biomarker
content/04. methodology.md:34:chromatographic
content/04. methodology.md:34:clinial
content/04. methodology.md:34:metabolomic
content/04. methodology.md:34:metabolomic
content/04. methodology.md:34:metabolomics
content/04. methodology.md:41:Multiomics
content/04. methodology.md:41:Spectrometry
content/04. methodology.md:43:metabolome
content/04. methodology.md:43:proteome
content/04. methodology.md:43:spectrometry
content/04. methodology.md:44:multiomic
content/04. methodology.md:44:omics
content/04. methodology.md:47:Cardiomyocytes
content/04. methodology.md:47:Metabolomics
content/04. methodology.md:47:Multiomics
content/04. methodology.md:47:Pluripotent
content/04. methodology.md:47:Proteomics
content/05.data-integration.md:1:Omic
content/05.data-integration.md:8:omics
content/05.data-integration.md:10:metabolomic
content/05.data-integration.md:10:multiomic
content/05.data-integration.md:10:proteomic
content/05.data-integration.md:12:Metabolomics
content/05.data-integration.md:12:omics
content/05.data-integration.md:14:metabolomics
content/05.data-integration.md:14:transcriptomics
content/05.data-integration.md:16:omics
content/05.data-integration.md:18:Omics
content/05.data-integration.md:20:mixOmics
content/05.data-integration.md:23:omics
content/05.data-integration.md:27:omics
content/05.data-integration.md:29:dataset
content/05.data-integration.md:29:omic
content/05.data-integration.md:33:dataset
content/05.data-integration.md:35:omic
content/05.data-integration.md:37:omic
content/05.data-integration.md:39:omic
content/05.data-integration.md:41:omics
content/05.data-integration.md:43:mixomics
content/05.data-integration.md:47:omics
content/05.data-integration.md:51:Metabolomics
content/05.data-integration.md:51:Proteomics
content/05.data-integration.md:54:omics
content/06.example-studies-model-organisms.md:1:Omics
content/06.example-studies-model-organisms.md:1:Spectrometry
content/06.example-studies-model-organisms.md:3:Cardiomyocytes
content/06.example-studies-model-organisms.md:3:Metabolomics
content/06.example-studies-model-organisms.md:3:Multiomics
content/06.example-studies-model-organisms.md:3:Pluripotent
content/06.example-studies-model-organisms.md:3:Proteomics
content/06.example-studies-model-organisms.md:6:Biogenesis
content/06.example-studies-model-organisms.md:6:omics
content/06.example-studies-model-organisms.md:9:multiomic
content/06.example-studies-model-organisms.md:9:spectrometry
content/06.example-studies-model-organisms.md:12:mitoprotease
content/06.example-studies-model-organisms.md:12:omic
content/06.example-studies-model-organisms.md:16:lipidomics
content/06.example-studies-model-organisms.md:16:proteomics
content/07.clinical-applications.md:1:lipidomics
content/07.clinical-applications.md:1:metabolomics
content/07.clinical-applications.md:1:omics
content/07.clinical-applications.md:1:proteomics
content/07.clinical-applications.md:3:omics
content/07.clinical-applications.md:3:proteogenomics
content/07.clinical-applications.md:3:proteome
content/07.clinical-applications.md:3:transcriptome
content/07.clinical-applications.md:5:phenotypes
content/07.clinical-applications.md:6:omics
content/07.clinical-applications.md:9:Adenoma
content/07.clinical-applications.md:9:adenomas
content/07.clinical-applications.md:9:adrenocorticotropic
content/07.clinical-applications.md:9:biomarkers
content/07.clinical-applications.md:9:Downregulated
content/07.clinical-applications.md:9:GC
content/07.clinical-applications.md:9:glycolysis
content/07.clinical-applications.md:9:metabolomic
content/07.clinical-applications.md:9:metabolomics
content/07.clinical-applications.md:9:Metabolomics
content/07.clinical-applications.md:9:Myc
content/07.clinical-applications.md:9:nano
content/07.clinical-applications.md:9:nanoLC
content/07.clinical-applications.md:9:proteomic
content/07.clinical-applications.md:9:proteomics
content/07.clinical-applications.md:9:Proteomics
content/07.clinical-applications.md:9:spectrometry
content/07.clinical-applications.md:9:spectrometry
content/07.clinical-applications.md:9:tumorigenesis
content/07.clinical-applications.md:9:tumorigenesis
content/07.clinical-applications.md:10:metabolomics
content/07.clinical-applications.md:10:proteomic
content/07.clinical-applications.md:10:spectrometry
content/07.clinical-applications.md:11:lipidomics
content/07.clinical-applications.md:11:lipidomics
content/07.clinical-applications.md:11:metabolome
content/07.clinical-applications.md:11:myeloma
content/07.clinical-applications.md:11:proteomics
content/07.clinical-applications.md:11:proteomics
content/07.clinical-applications.md:11:untargeted
content/07.clinical-applications.md:12:metabolome
content/07.clinical-applications.md:12:proteome
content/07.clinical-applications.md:12:Proteometabolomics
content/07.clinical-applications.md:13:Metabolomics
content/07.clinical-applications.md:13:Proteomics
content/07.clinical-applications.md:15:COVID
content/07.clinical-applications.md:16:biomarkers
content/07.clinical-applications.md:16:COVID
content/07.clinical-applications.md:16:COVID
content/07.clinical-applications.md:16:COVID
content/07.clinical-applications.md:16:degranulation
content/07.clinical-applications.md:16:Dysregulation
content/07.clinical-applications.md:16:macrophage
content/07.clinical-applications.md:16:metabolomic
content/07.clinical-applications.md:16:Metabolomic
content/07.clinical-applications.md:16:metabolomics
content/07.clinical-applications.md:16:proteomic
content/07.clinical-applications.md:16:Proteomic
content/07.clinical-applications.md:16:proteomics
content/07.clinical-applications.md:16:Sera
content/07.clinical-applications.md:16:spectrometry
content/07.clinical-applications.md:16:TMTpro
content/07.clinical-applications.md:16:untargeted
content/07.clinical-applications.md:16:UPLC
content/07.clinical-applications.md:17:CoV
content/07.clinical-applications.md:17:COVID
content/07.clinical-applications.md:17:COVID
content/07.clinical-applications.md:17:omic
content/07.clinical-applications.md:17:pts
content/07.clinical-applications.md:18:COVID
content/07.clinical-applications.md:18:lipidomic
content/07.clinical-applications.md:18:Metabolomic
content/07.clinical-applications.md:18:tocilizumab
content/07.clinical-applications.md:19:COVID
content/07.clinical-applications.md:19:Omics
content/07.clinical-applications.md:20:COVID
content/07.clinical-applications.md:20:Omics
content/07.clinical-applications.md:21:COVID
content/07.clinical-applications.md:21:erythroid
content/07.clinical-applications.md:21:megakaryocytes
content/07.clinical-applications.md:21:omics
content/07.clinical-applications.md:21:plasmablasts
content/07.clinical-applications.md:24:biomarker
content/07.clinical-applications.md:24:biomarkers
content/07.clinical-applications.md:24:biomarkers
content/07.clinical-applications.md:24:CSF
content/07.clinical-applications.md:24:metabolomics
content/07.clinical-applications.md:24:omics
content/07.clinical-applications.md:24:omics
content/07.clinical-applications.md:24:proide
content/07.clinical-applications.md:24:proteomics
content/07.clinical-applications.md:24:proteomics
content/07.clinical-applications.md:24:synergize
content/07.clinical-applications.md:25:aptamer
content/07.clinical-applications.md:25:bariatric
content/07.clinical-applications.md:25:diabetogenic
content/07.clinical-applications.md:25:GH
content/07.clinical-applications.md:25:GHR
content/07.clinical-applications.md:25:glycemic
content/07.clinical-applications.md:25:metabolome
content/07.clinical-applications.md:25:metabolome
content/07.clinical-applications.md:25:metabolomics
content/07.clinical-applications.md:25:Metabolon
content/07.clinical-applications.md:25:proteome
content/07.clinical-applications.md:25:proteome
content/07.clinical-applications.md:25:proteome
content/07.clinical-applications.md:25:RYGB
content/07.clinical-applications.md:25:RYGB
content/07.clinical-applications.md:25:SOMAscan
content/07.clinical-applications.md:25:spectrometry
content/07.clinical-applications.md:25:UPLC
